The FDA’s Endocrinologic and Metabolic Drugs Advisory Committee voted unanimously Nov. 14 to recommend an expanded indication for icosapent ethyl, a purified omega-3 product designed to help heart patients keep their lipid levels in check.

Research that will be presented at the American Heart Association’s Resuscitation Science Symposium in Philadelphia this month suggests the National Institutes of Health invests far less money in cardiac arrest research than in research for other conditions, including diabetes, drug-use disorders and ischemic heart disease.

Young people who use cannabis—especially if they’re frequent users—could face an up to threefold increased risk of stroke compared to their peers, researchers have found.

A collaboration between physicists and cardiologists at the University of California San Diego has resulted in an AI tool that can predict heart failure patients’ life expectancy with 88% accuracy.

Taller people might be at an increased risk for atrial fibrillation, according to research set for presentation at the American Heart Association’s Scientific Sessions on Nov. 16.

Research out of Peking University in Beijing, China, has established a link between insomnia and heart disease, ABC News reports.

Millions of Americans are unaware of common heart attack symptoms, according to researchers, including a subset of 13.5 million people who admit to not knowing a single symptom of MI.

Research published in JAMA Nov. 12 suggests that, despite the Organ Procurement and Transplant Network’s overhaul of the U.S. heart allocation system in 2018, CV transplant programs still suffer from variability in survival benefit and a lack of standardized guidelines for ranking candidates.